$XBIT
XBiotech Inc

2023 Q1 Form 10-K Financial Statement

#000117184323001705 Filed on March 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022 Q2
Revenue $0.00 $300.0K $1.530M
YoY Change -100.0% -93.33% -66.19%
Cost Of Revenue $0.00 $16.00K $207.0K
YoY Change -100.0% -98.47% -84.78%
Gross Profit $0.00 $284.0K $1.323M
YoY Change -100.0% -91.78% -58.2%
Gross Profit Margin 94.67% 86.47%
Selling, General & Admin $915.0K $1.129M $3.023M
YoY Change -30.37% -39.5% -33.06%
% of Gross Profit 397.54% 228.5%
Research & Development $6.230M $7.317M $10.39M
YoY Change -8.62% -16.68% 12.32%
% of Gross Profit 2576.41% 785.64%
Depreciation & Amortization $443.0K $443.0K $727.0K
YoY Change -37.61% -36.89% 13.77%
% of Gross Profit 155.99% 54.95%
Operating Expenses $7.145M $8.446M $13.42M
YoY Change -12.14% -20.68% -2.56%
Operating Profit -$7.145M -$8.162M -$12.09M
YoY Change -8.92% 13.47% 14.04%
Interest Expense $3.162M $5.539M -$2.039M
YoY Change 127.32% -1268.57% -322.6%
% of Operating Profit
Other Income/Expense, Net $3.292M -$2.000K -$119.0K
YoY Change 136.66% -113.02%
Pretax Income -$3.853M -$2.625M -$14.25M
YoY Change -40.3% -65.77% 47.06%
Income Tax -$37.00K $578.0K -$2.608M
% Of Pretax Income
Net Earnings -$3.816M -$3.203M -$11.64M
YoY Change -29.27% -50.47% 127.51%
Net Earnings / Revenue -1067.67% -761.05%
Basic Earnings Per Share -$0.13 -$0.10 -$0.38
Diluted Earnings Per Share -$0.13 -$0.11 -$382.5K
COMMON SHARES
Basic Shares Outstanding 30.44M 30.44M 30.44M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q4 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $212.7M $217.5M $225.8M
YoY Change -8.26% -8.23% -28.38%
Cash & Equivalents $152.5M $157.3M $225.8M
Short-Term Investments $60.18M $60.17M
Other Short-Term Assets $703.0K $601.0K $545.0K
YoY Change 11.23% -35.65% -62.95%
Inventory
Prepaid Expenses
Receivables $2.371M $1.216M
Other Receivables $548.0K $548.0K
Total Short-Term Assets $216.3M $219.8M $238.8M
YoY Change -10.99% -10.95% -26.5%
LONG-TERM ASSETS
Property, Plant & Equipment $25.84M $26.26M $27.28M
YoY Change -7.14% -7.23% -4.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $422.0K
YoY Change -34.27%
Total Long-Term Assets $25.84M $26.26M $27.70M
YoY Change -7.14% -7.23% -4.79%
TOTAL ASSETS
Total Short-Term Assets $216.3M $219.8M $238.8M
Total Long-Term Assets $25.84M $26.26M $27.70M
Total Assets $242.1M $246.1M $266.5M
YoY Change -10.59% -10.57% -24.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.357M $2.408M $2.454M
YoY Change 2.57% 16.38% 64.59%
Accrued Expenses $2.206M $1.603M $5.588M
YoY Change 40.69% 16.67% 232.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.618M $4.066M $8.235M
YoY Change 25.15% 17.75% 111.64%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.598M $1.576M $1.559M
YoY Change 8.05% 7.5% 11.92%
Total Long-Term Liabilities $1.598M $1.576M $1.559M
YoY Change 8.05% 7.5% 11.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.618M $4.066M $8.235M
Total Long-Term Liabilities $1.598M $1.576M $1.559M
Total Liabilities $5.216M $5.701M $10.67M
YoY Change -0.51% -1.57% 97.83%
SHAREHOLDERS EQUITY
Retained Earnings -$31.57M -$27.75M
YoY Change 12836.48% -638.71%
Common Stock $268.0M $267.3M
YoY Change 1.64% 1.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $236.9M $240.4M $255.8M
YoY Change
Total Liabilities & Shareholders Equity $242.1M $246.1M $266.5M
YoY Change -10.59% -10.57% -24.72%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022 Q2
OPERATING ACTIVITIES
Net Income -$3.816M -$3.203M -$11.64M
YoY Change -29.27% -50.47% 127.51%
Depreciation, Depletion And Amortization $443.0K $443.0K $727.0K
YoY Change -37.61% -36.89% 13.77%
Cash From Operating Activities -$4.808M $2.703M -$6.377M
YoY Change -6.15% -253.67% -108.76%
INVESTING ACTIVITIES
Capital Expenditures $6.000K $132.0K -$82.00K
YoY Change -96.27% -127.73% -95.2%
Acquisitions
YoY Change
Other Investing Activities -$3.775M
YoY Change
Cash From Investing Activities -$6.000K -$3.907M -$82.00K
YoY Change -96.27% 720.8% -95.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -$4.808M 2.703M -6.377M
Cash From Investing Activities -$6.000K -3.907M -82.00K
Cash From Financing Activities $0.00 0.000 0.000
Net Change In Cash -$4.822M -1.204M -6.459M
YoY Change -6.59% -45.32% -108.6%
FREE CASH FLOW
Cash From Operating Activities -$4.808M $2.703M -$6.377M
Capital Expenditures $6.000K $132.0K -$82.00K
Free Cash Flow -$4.814M $2.571M -$6.295M
YoY Change -8.89% -300.39% -108.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2021Q4 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2022 us-gaap Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
Unlimited
CY2021 us-gaap Preferred Stock Shares Authorized Unlimited
PreferredStockSharesAuthorizedUnlimited
Unlimited
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2021Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2021 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30439275
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30439275
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30439275
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30439275
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
246103000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.92
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.29
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2021 us-gaap Depreciation
Depreciation
2600000 usd
CY2022Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y1M13D
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y5M1D
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-688000 usd
CY2022Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
1400000 usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-37437
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
A1
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
5217 Winnebago Ln
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78744
CY2022 dei City Area Code
CityAreaCode
512
CY2022 dei Local Phone Number
LocalPhoneNumber
386-2900
CY2022 dei Security12b Title
Security12bTitle
Common Stock, no par value
CY2022 dei Trading Symbol
TradingSymbol
XBIT
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
132808406 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30439275
CY2022 dei Auditor Firm
AuditorFirmId
726
CY2021 dei Auditor Firm
AuditorFirmId
42
CY2022 dei Auditor Name
AuditorName
Whitley Penn LLP
CY2022 dei Auditor Location
AuditorLocation
Austin, Texas
CY2021 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2021 dei Auditor Location
AuditorLocation
Austin, Texas
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
157306000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
236983000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
60172000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
1216000 usd
CY2021Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
0 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
548000 usd
CY2021Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
8953000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
601000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
934000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
219843000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
246870000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
26260000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28307000 usd
CY2022Q4 us-gaap Assets
Assets
246103000 usd
CY2021Q4 us-gaap Assets
Assets
275177000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2408000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2069000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1603000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1374000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
55000 usd
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
10000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4066000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3453000 usd
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1576000 usd
CY2021Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
1466000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
59000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
873000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
5701000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
5792000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
267325000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
262263000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
826000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1971000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27749000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5151000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
240402000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
269385000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
275177000 usd
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4010000 usd
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
18394000 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
651000 usd
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5820000 usd
CY2022 us-gaap Gross Profit
GrossProfit
3359000 usd
CY2021 us-gaap Gross Profit
GrossProfit
12574000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31544000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28268000 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6305000 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9388000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
37849000 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
37656000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-34490000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-25082000 usd
CY2022 us-gaap Investment Income Net
InvestmentIncomeNet
3823000 usd
CY2021 us-gaap Investment Income Net
InvestmentIncomeNet
467000 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-121000 usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-132000 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2800000 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-711000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
902000 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-376000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33588000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25458000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-688000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8044000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-32900000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-17414000 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.08
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30439275
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30043380
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.08
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30439275
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30043380
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-32900000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-17414000 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
1567000 usd
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
-0 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
422000 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
705000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34045000 usd
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16709000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
348639000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-17414000 usd
CY2021 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
705000 usd
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7995000 usd
CY2021 us-gaap Dividends Common Stock
DividendsCommonStock
75003000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4463000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
269385000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-32900000 usd
CY2022 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
422000 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax
1567000 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5062000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
240402000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-32900000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-17414000 usd
CY2022 us-gaap Depreciation
Depreciation
2614000 usd
CY2021 us-gaap Depreciation
Depreciation
2648000 usd
CY2022 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-2800000 usd
CY2021 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-0 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
5062000 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
4463000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-0 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4113000 usd
CY2022 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-8556000 usd
CY2021 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
2380000 usd
CY2022 xbit Increase Decrease In Deferred Cost Of Goods Sold
IncreaseDecreaseInDeferredCostOfGoodsSold
-0 usd
CY2021 xbit Increase Decrease In Deferred Cost Of Goods Sold
IncreaseDecreaseInDeferredCostOfGoodsSold
-2177000 usd
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
1216000 usd
CY2021 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-0 usd
CY2022 xbit Amount Held In Escrow
AmountHeldInEscrow
0 usd
CY2021 xbit Amount Held In Escrow
AmountHeldInEscrow
75063000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-334000 usd
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
352000 usd
CY2022 xbit Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
-0 usd
CY2021 xbit Increase Decrease In Deferred Tax Assets
IncreaseDecreaseInDeferredTaxAssets
-533000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
357000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-514000 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
229000 usd
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
23000 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
155000 usd
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
212000 usd
CY2022 xbit Increase Decrease In Deferred Tax Liability
IncreaseDecreaseInDeferredTaxLiability
-815000 usd
CY2021 xbit Increase Decrease In Deferred Tax Liability
IncreaseDecreaseInDeferredTaxLiability
873000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-14824000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
69445000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
585000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3525000 usd
CY2022 us-gaap Payments To Acquire Restricted Certificates Of Deposit
PaymentsToAcquireRestrictedCertificatesOfDeposit
63307000 usd
CY2021 us-gaap Payments To Acquire Restricted Certificates Of Deposit
PaymentsToAcquireRestrictedCertificatesOfDeposit
-0 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-63892000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3525000 usd
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
-0 usd
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
75003000 usd
CY2022 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
0 usd
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7995000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-67008000 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-961000 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
705000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-79677000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-383000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
236983000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
237366000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
157306000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
236983000 usd
CY2022 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
18000 usd
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
93000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
157300000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.023 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.022 pure
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The preparation of financial statements in accordance with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported values of amounts in the financial statements and accompanying notes. Actual results could differ from those estimates.</p>
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5062000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4463000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.058 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.030 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.002 pure
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Concentrations of Credit Risk </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">Financial instruments that potentially subject the Company to credit risk consist primarily of cash and cash equivalents. The Company holds these investments in highly-rated financial institutions, and limits the amounts of credit exposure to any <em style="font: inherit;">one</em> financial institution. These amounts at times <em style="font: inherit;"> may </em>exceed federally insured limits. The Company has <em style="font: inherit;">not</em> experienced any credit losses in such accounts and does <em style="font: inherit;">not</em> believe it is exposed to any significant credit risk on these funds. The Company has <em style="font: inherit;">no</em> off-balance sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.003 pure
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.020 pure
CY2022 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4000000.0 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16495000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
15732000 usd
CY2022Q4 xbit Property Plant And Equipment Including Building Construction In Process
PropertyPlantAndEquipmentIncludingBuildingConstructionInProcess
26260000 usd
CY2021Q4 xbit Property Plant And Equipment Including Building Construction In Process
PropertyPlantAndEquipmentIncludingBuildingConstructionInProcess
28307000 usd
CY2022 us-gaap Depreciation
Depreciation
2600000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
489000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
480000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
117000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
163000 usd
CY2022Q4 xbit Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
928000 usd
CY2021Q4 xbit Accrued Clinical Trial Expenses Current
AccruedClinicalTrialExpensesCurrent
618000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
69000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
113000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1603000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1374000 usd
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1100000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8000000.0 usd
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
-0.003 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Contingencies
EffectiveIncomeTaxRateReconciliationTaxContingencies
-0.015 pure
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5327425
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
809500
CY2021 xbit Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercises In Period Net
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisesInPeriodNet
1348374
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
131874
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4656677
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
152600
CY2022 xbit Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercises In Period Net
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisesInPeriodNet
-0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
250375
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4558902
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2800000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
4100000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.32
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-32900000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-17414000 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30439275
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30043380
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.08
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.58
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30439275
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30043380
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.08
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.58
CY2022 xbit Effective Income Tax Rate Reconciliation Foreign Exchange Gain Loss Percent
EffectiveIncomeTaxRateReconciliationForeignExchangeGainLossPercent
-0.016 pure
CY2021 xbit Effective Income Tax Rate Reconciliation Foreign Exchange Gain Loss Percent
EffectiveIncomeTaxRateReconciliationForeignExchangeGainLossPercent
0.015 pure
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33588000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-25458000 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
457000 usd
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
17000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-334000 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-9486000 usd
CY2022 xbit Current Other Tax Expense Benefit
CurrentOtherTaxExpenseBenefit
5000 usd
CY2021 xbit Current Other Tax Expense Benefit
CurrentOtherTaxExpenseBenefit
14000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
128000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-9455000 usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-805000 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
1505000 usd
CY2022 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-11000 usd
CY2021 us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-94000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-816000 usd
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1411000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8044000 usd
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.270 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.270 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
-0.041 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
-0.009 pure
CY2022 xbit Effective Income Tax Rate Reconciliation Capital Gain Exclusion Percent
EffectiveIncomeTaxRateReconciliationCapitalGainExclusionPercent
0.000 pure
CY2021 xbit Effective Income Tax Rate Reconciliation Capital Gain Exclusion Percent
EffectiveIncomeTaxRateReconciliationCapitalGainExclusionPercent
0.000 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.146 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.041 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.035 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.016 pure
CY2022 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.004 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
0.009 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.316 pure
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
0 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
112000 usd
CY2022Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
3820000 usd
CY2021Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
3360000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2703000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3235000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
5210000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
0 usd
CY2022Q4 xbit Deferred Tax Assets Share Issuance Costs
DeferredTaxAssetsShareIssuanceCosts
229000 usd
CY2021Q4 xbit Deferred Tax Assets Share Issuance Costs
DeferredTaxAssetsShareIssuanceCosts
425000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
294000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
227000 usd
CY2022Q4 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
687000 usd
CY2021Q4 us-gaap Deferred Tax Assets Unrealized Currency Losses
DeferredTaxAssetsUnrealizedCurrencyLosses
206000 usd
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
12944000 usd
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
7565000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11225000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
6474000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1719000 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1091000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
710000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
824000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
93000 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
69000 usd
CY2022Q4 xbit Deferred Tax Liabilities Uncollectible Debts
DeferredTaxLiabilitiesUncollectibleDebts
975000 usd
CY2021Q4 xbit Deferred Tax Liabilities Uncollectible Debts
DeferredTaxLiabilitiesUncollectibleDebts
1057000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities Unrealized Currency Transaction Gains
DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains
0 usd
CY2021Q4 us-gaap Deferred Tax Liabilities Unrealized Currency Transaction Gains
DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains
14000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1777000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
1964000 usd
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
59000 usd
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
873000 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2389000 usd
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2060000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
130000 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
42000 usd
CY2022 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
346000 usd
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
287000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2864000 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2389000 usd
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
63000 usd
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
56000 usd
CY2022Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1600000 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
1500000 usd
CY2022Q4 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
500000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7845000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-12094000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6389000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-8162000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-5395000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11644000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-12658000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-3203000 usd
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.42
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3553000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10605000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3731000 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-7193000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2568000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-5118000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3261000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-6467000 usd
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.21

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001171843-23-001705-index-headers.html Edgar Link pending
0001171843-23-001705-index.html Edgar Link pending
0001171843-23-001705.txt Edgar Link pending
0001171843-23-001705-xbrl.zip Edgar Link pending
exh1013_01.jpg Edgar Link pending
exh1013_02.jpg Edgar Link pending
exh1013_03.jpg Edgar Link pending
exh1013_04.jpg Edgar Link pending
exh1013_05.jpg Edgar Link pending
exh1013_06.jpg Edgar Link pending
exh1013_07.jpg Edgar Link pending
exh1013_08.jpg Edgar Link pending
exh1013_09.jpg Edgar Link pending
exh1014_01.jpg Edgar Link pending
exh1014_02.jpg Edgar Link pending
exh1014_03.jpg Edgar Link pending
exh1014_04.jpg Edgar Link pending
ex_484791.htm Edgar Link pending
ex_484792.htm Edgar Link pending
ex_484793.htm Edgar Link pending
ex_484794.htm Edgar Link pending
ex_484795.htm Edgar Link pending
ex_484796.htm Edgar Link pending
ex_484797.htm Edgar Link pending
ex_484802.htm Edgar Link pending
ex_485101.htm Edgar Link pending
ex_485102.htm Edgar Link pending
ex_485115.htm Edgar Link pending
ex_485116.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
productpipeline.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xbit-20221231.xsd Edgar Link pending
xbit20221231_10k.htm Edgar Link pending
xbit-20221231_cal.xml Edgar Link unprocessable
xbit-20221231_def.xml Edgar Link unprocessable
xbit-20221231_lab.xml Edgar Link unprocessable
xbit-20221231_pre.xml Edgar Link unprocessable
xbit20221231_10k_htm.xml Edgar Link completed